Adam Luginbuhl

14PUBLICATIONS
90CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersComparative and cross-cultural education
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 03, 2026
Translational Opportunity of Engineered IFNγ-eEVs Through Targeted Inhibition of JAK/STAT1 Signaling, Mimicking IVIg Therapy.

|Dec 12, 2025
Neoadjuvant nivolumab plus carboplatin and paclitaxel in patients with locally advanced resectable squamous cell carcinoma of the head and neck: a phase II, single-arm trial.

Ralph G Zinner, Eric V Mastrolonardo, Jennifer M Johnson

|Sep 11, 2025
Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC.

Pablo Llerena, Hani Samarah, Kathryn Nunes

|Nov 25, 2024
Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma.

Eric V Mastrolonardo, Kathryn L Nunes, Pablo Llerena

|Nov 12, 2024
A Randomized Pilot Trial of Virtual Reality Surgical Planning for Head and Neck Oncologic Resection.

Kathryn L Nunes, Victor Jegede, Derek S Mann

|Aug 23, 2023
A Survey of Microvascular Technique Preferences Among American Head Neck Society Members.

Ramez Philips, Keisha A Best, Aarti Agarwal

Pageof 3

Frequent Collaborators

4 joint publications

Larry Harshyne

4 joint publications

Ramez Philips

4 joint publications

Joseph M Curry

4 joint publications

Pablo Llerena